Literature DB >> 3093039

The effects of desmopressin on hemostatic parameters in the normal dog.

I B Johnstone, S Crane.   

Abstract

Seven normal unanesthetized dogs were infused with desmopressin in saline (doses 0.2, 0.4 and 0.6 micrograms/kg i.v.) or saline alone, on separate occasions in order to determine the effects of desmopressin on circulating factor VIII coagulant and factor VIII-related antigen activities, on partial thromboplastin times and prothrombin times, on blood platelet count and packed cell volume, and on serum osmolarity. Desmopressin caused a rapid dose-dependent elevation in both factor VIII activities peaking at 30-60 minutes postinfusion. At a dosage of 0.6 microgram/kg desmopressin induced rises in factor VIII coagulant activity and factor VIII-related antigen of 150% and 198% of the preinfusion levels respectively, while the half disappearance times were approximately five and six hours respectively. The other parameters were not significantly affected by even the highest dose of desmopressin used. These results indicate that normal dogs respond to desmopressin in a manner similar to man. The major differences are in the dosage required to produce comparable effects (higher in dogs), and in the fact that the factor VIII-related antigen activity consistently responds to a greater degree than the coagulant activity. It is concluded that desmopressin may have particular value in stimulating elevations in plasma factor VIII-related antigen in dogs deficient in this plasma protein. Six dogs were pretreated with the endorphin inhibitor, naloxone, (0.04 mg/kg I.V.) or sterile saline, three minutes prior to infusion with desmopressin at a dose of 0.6 microgram/kg i.v.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093039      PMCID: PMC1255201     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  20 in total

1.  DDAVP in von Willebrand's disease: repeated administration and the behaviour of the bleeding time.

Authors:  W Theiss; G Schmidt
Journal:  Thromb Res       Date:  1978-12       Impact factor: 3.944

Review 2.  The factor VIII complex: structure and function.

Authors:  L W Hoyer
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

3.  Synthesis and release of factor VIII by cultured human endothelial cells.

Authors:  E G Tuddenham; J Lazarchick; L W Hoyer
Journal:  Br J Haematol       Date:  1981-04       Impact factor: 6.998

4.  Von Willebrand's disease in two families of Doberman Pinschers.

Authors:  I B Johnstone; S Crane
Journal:  Can Vet J       Date:  1981-08       Impact factor: 1.008

5.  Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.

Authors:  P A Ockelford; N C Menon; E W Berry
Journal:  N Z Med J       Date:  1980-11-26

6.  Evidence for endogenous opioid control of vasopressin release in man.

Authors:  S L Lightman; M L Forsling
Journal:  J Clin Endocrinol Metab       Date:  1980-03       Impact factor: 5.958

7.  The role of the spleen in regulating the plasma levels of factor VIII--von Willebrand's factor after DDAVP.

Authors:  V V Garcia; R Coppola; P M Mannucci
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

8.  Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.

Authors:  P M Mannucci; M T Canciani; L Rota; B S Donovan
Journal:  Br J Haematol       Date:  1981-02       Impact factor: 6.998

9.  A canine model of hemophilic (factor VIII:C deficiency) bleeding.

Authors:  A R Giles; S Tinlin; R Greenwood
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

10.  Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.

Authors:  C A Ludlam; I R Peake; N Allen; B L Davies; R A Furlong; A L Bloom
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

View more
  5 in total

1.  Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1999-09       Impact factor: 1.008

2.  Hemostatic studies in a newfoundland dog with idiopathic epistaxis.

Authors:  I B Johnstone; M Macleod
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

3.  The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

4.  Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

5.  Canine Von Willebrand's Disease: A Common Inherited Bleeding Disorder in Doberman Pinscher Dogs.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1986-09       Impact factor: 1.008

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.